Cargando…
The patient perspective on vaccine uptake in adults with psoriasis and eczema
Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904245/ https://www.ncbi.nlm.nih.gov/pubmed/36749390 http://dx.doi.org/10.1007/s00403-023-02546-0 |
_version_ | 1784883581557932032 |
---|---|
author | Noe, Megan H. Archila, Marjorie Barbieri, John S. Goldman, Nathaniel Lopez, Christina G. Mostaghimi, Arash Scherer, Aaron M. Tan, Alice J. Perez-Chada, Lourdes M. Asgari, Maryam M. Gelfand, Joel M. |
author_facet | Noe, Megan H. Archila, Marjorie Barbieri, John S. Goldman, Nathaniel Lopez, Christina G. Mostaghimi, Arash Scherer, Aaron M. Tan, Alice J. Perez-Chada, Lourdes M. Asgari, Maryam M. Gelfand, Joel M. |
author_sort | Noe, Megan H. |
collection | PubMed |
description | Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated with vaccine uptake and barriers to vaccination in adults with psoriasis and eczema. Virtual, video-based semi-structured interviews were performed with adults who self-reported a diagnosis of psoriasis or eczema. Interviews explored themes around healthcare decision making, perceived risks/benefits to vaccination, barriers, and vaccine knowledge. Thematic analysis was used to analyze the data. Of 34 study participants, 25 participants (74%) were females and 9 (26%) were males, with a mean age of 50.8 years (SD: 16.4, range: 24–71 yrs). Half of participants (n = 17) had psoriasis, and half (n = 17) had eczema. Participants recognized both personal and societal benefits to vaccines. Common vaccination barriers identified were access to appointments, concerns about side effects, and misinformation. Physicians, friends/family, and media, including internet resources, were health information resources identified by patients. These results summarize the unique patient perspective around vaccine uptake in adults with eczema and psoriasis and represent an important first step in a multi-pronged approach to improve vaccination rates in adults with chronic skin diseases. |
format | Online Article Text |
id | pubmed-9904245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-99042452023-02-07 The patient perspective on vaccine uptake in adults with psoriasis and eczema Noe, Megan H. Archila, Marjorie Barbieri, John S. Goldman, Nathaniel Lopez, Christina G. Mostaghimi, Arash Scherer, Aaron M. Tan, Alice J. Perez-Chada, Lourdes M. Asgari, Maryam M. Gelfand, Joel M. Arch Dermatol Res Original Paper Having a chronic disease is one of the most consistent factors associated with vaccine uptake for adults in the general population, but vaccination beliefs and behaviors specific to those with chronic skin diseases have not been explored. The objective of this study was to explore factors associated with vaccine uptake and barriers to vaccination in adults with psoriasis and eczema. Virtual, video-based semi-structured interviews were performed with adults who self-reported a diagnosis of psoriasis or eczema. Interviews explored themes around healthcare decision making, perceived risks/benefits to vaccination, barriers, and vaccine knowledge. Thematic analysis was used to analyze the data. Of 34 study participants, 25 participants (74%) were females and 9 (26%) were males, with a mean age of 50.8 years (SD: 16.4, range: 24–71 yrs). Half of participants (n = 17) had psoriasis, and half (n = 17) had eczema. Participants recognized both personal and societal benefits to vaccines. Common vaccination barriers identified were access to appointments, concerns about side effects, and misinformation. Physicians, friends/family, and media, including internet resources, were health information resources identified by patients. These results summarize the unique patient perspective around vaccine uptake in adults with eczema and psoriasis and represent an important first step in a multi-pronged approach to improve vaccination rates in adults with chronic skin diseases. Springer Berlin Heidelberg 2023-02-07 /pmc/articles/PMC9904245/ /pubmed/36749390 http://dx.doi.org/10.1007/s00403-023-02546-0 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Noe, Megan H. Archila, Marjorie Barbieri, John S. Goldman, Nathaniel Lopez, Christina G. Mostaghimi, Arash Scherer, Aaron M. Tan, Alice J. Perez-Chada, Lourdes M. Asgari, Maryam M. Gelfand, Joel M. The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title | The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title_full | The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title_fullStr | The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title_full_unstemmed | The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title_short | The patient perspective on vaccine uptake in adults with psoriasis and eczema |
title_sort | patient perspective on vaccine uptake in adults with psoriasis and eczema |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904245/ https://www.ncbi.nlm.nih.gov/pubmed/36749390 http://dx.doi.org/10.1007/s00403-023-02546-0 |
work_keys_str_mv | AT noemeganh thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT archilamarjorie thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT barbierijohns thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT goldmannathaniel thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT lopezchristinag thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT mostaghimiarash thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT schereraaronm thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT tanalicej thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT perezchadalourdesm thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT asgarimaryamm thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT gelfandjoelm thepatientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT noemeganh patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT archilamarjorie patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT barbierijohns patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT goldmannathaniel patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT lopezchristinag patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT mostaghimiarash patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT schereraaronm patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT tanalicej patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT perezchadalourdesm patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT asgarimaryamm patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema AT gelfandjoelm patientperspectiveonvaccineuptakeinadultswithpsoriasisandeczema |